Dietary Supplement Firms, CGMPs and the Park Doctrine
Editor’s Note: This article is written by Contributing Writer Shafiel A. Karim. As FDA continues to inspect dietary supplement manufacturers under the new CGMP framework, it is clear that many manufacturers share similar deficiencies. Recent FDA warning letters show that many manufacturers are still struggling with structure function claims, the required pre- and post-production qualitative [...]